Gastroenterology
Feature
What to Know About the Next-Gen FIT for CRC Screening
These multitarget approaches take the standard FIT a step further by testing for additional DNA, RNA, or protein biomarkers associated with CRC to...
Conference Coverage
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Cancer
Researchers develop signature for pancreatic cancer based on microRNAs and cell-free DNA markers in the blood of patients with the disease.
Conference Coverage
Combo Therapy Prolongs Survival in Gastric Cancer Patients, Regardless of PD-L1 Expression
Researchers evaluate the efficacy and safety of first-line cadonilimab plus standard chemotherapy in patients with advanced or metastatic gastric...
From the Journals
New Quality Measure Improves Follow-Up for CRC Screening
Field testing shows that this CRC screening tracker is “feasible, valid, and reliable.”
From the Journals
Eliminating H pylori Lowers CRC Incidence, Mortality Risk
Investigators review CRC incidence and mortality in a nationwide cohort of veterans tested for H pylori.
Feature
Should Opioids Be Used for Chronic Cancer Pain?
Prescribing strategies are partly driven by peer pressure, new research suggests.
Conference Coverage
Certain Pesticides Linked With Risk for Pancreatic Cancer
Researcher divided the entire French territory into 5529 spatial units and determined the number of pancreatic cancer cases per spatial unit per...
From the Journals
Active Surveillance for Cancer Doesn’t Increase Malpractice Risk
Researchers identify malpractice trends involving active surveillance related to thyroid, prostate, kidney, and...
Commentary
Diarrhea in Cancer Therapies — Part 1: Chemotherapeutics
Oncologist and gastroenterologist discuss treatment methods and guidelines for patients experiencing diarrhea from chemotherapy.
News
Liquid Biopsy for Colorectal Cancer Appears Promising But Still Lacks Robust Efficacy
Patients who may have declined colonoscopy should understand the need for a colonoscopy if blood-based tests show abnormal results.
From the Journals
Few Childhood Cancer Survivors Get Recommended Screenings
‘As many as four out of five of these survivors will develop a serious or life-threatening late effect of their cancer therapy by age 45,’ the...